中恒集团 (600252)

Guangxi Wuzhou Zhongheng Group Co., Ltd.

ASH

Tags

SSE 580 IndexTraditional Chinese MedicineCSI Share Buyback IndexLow-Price StocksVenture Capital ConceptInnovative DrugsDebt Resolution AMCPharmaceutical ManufacturingPharmaceuticals and HealthcareInvestments in Financial InstitutionsFace Mask ProtectionHelicobacter PyloriLow-Profit StocksCommitment Not to Reduce HoldingsBaijiu (Chinese Liquor) ConceptHepatitis ConceptEquity TransferMargin Trading and Securities LendingChina Securities Finance and Central Huijin Holdings中药Ⅱ医药生物

K-Line Chart

No K-line data available

Company NameGuangxi Wuzhou Zhongheng Group Co., Ltd.
Listing Date2000-11-30
Issue Price5.25RMB
Registered Capital318416.30710k RMB
Legal RepresentativeYang Jinhai
Registered AddressBuilding 1, No. 1 Industrial Avenue, Wuzhou Industrial Park, Guangxi
IndustryTraditional Chinese Medicine II
Main BusinessPharmaceutical and medical protective equipment manufacturing, food production, and planting sector
Company ProfileGuangxi Wuzhou Zhongheng Group Co., Ltd. (abbreviated as Zhongheng Group) is a diversified industrial group and listed company (stock code: 600252) primarily focused on pharmaceuticals, with extended sectors including health food. It is a National High-Tech Enterprise and ranks among China's Top 100 Pharmaceutical Industrial Enterprises. The group's main subsidiaries include Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (abbreviated as Wuzhou Pharmaceutical) and Guangxi Wuzhou Shuangqian Industrial Co., Ltd. (abbreviated as Shuangqian Industrial). Wuzhou Pharmaceutical is a shining pearl in China's modern traditional Chinese medicine industry. Through nearly 90 years of innovative development, it possesses leading domestic product resources and advanced industry technologies, with continuously improving independent innovation capabilities. It has successfully developed high-tech branded products such as Xueshuantong for Injection, Zhonghua Dieda Pills, and Fuyanjing Capsules, demonstrating prominent advantages in therapeutic areas including cardiovascular and cerebrovascular diseases, trauma and injuries, gynecological diseases, and respiratory system disorders. Wuzhou Pharmaceutical was awarded the National Science and Technology Progress Second Prize in 2016.

Stock Details

1. Key Indicators

  • Total Shares(W): 319522.84
  • Circulating A-Shares(W): 318416.31
  • Earnings Per Share(RMB): 0.0078
  • Net Assets Per Share(RMB): 1.8151
  • Operating Revenue(W RMB): 194813.10
  • Total Profit(W RMB): 1105.97
  • **Net Profit Attributable to Parent(W RMB) **: 2464.04
  • Net Profit Growth Rate(%): 119.61
  • Weighted Return on Equity(%): 0.4000
  • Operating Cash Flow Per Share(RMB): -0.0490
  • Undistributed Profit Per Share(RMB): 0.6093
  • Capital Reserve Per Share(RMB): 0.0001

2. Main Business

The main business covers:

  • Pharmaceutical manufacturing
  • Real estate development and operation
  • Electric power
  • Construction
  • Hotel and tourism services

3. Company Basic Information

  • Company Name: Guangxi Wuzhou Zhongheng Group Co., Ltd.
  • Listing Date: 2000-11-30
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 1 Industrial Avenue, Wuzhou Industrial Park, Guangxi Zhuang Autonomous Region
  • Website: http://www.wz-zhongheng.com
  • Company Profile: The company was restructured in 1993 from Wuzhou Urban Construction Comprehensive Development Company, jointly initiated by Wuzhou Real Estate Development Co., Ltd. and Wuzhou Urban Construction Design Institute, absorbing other legal entities and internal employees through a directed placement. The total share capital was 61.74925 million shares. In December 1993, it was renamed "Guangxi Wuzhou Zhongfang Co., Ltd." After a capital increase in December 1994, the total share capital became 86.74925 million shares. In 1996, after repurchasing corporate shares, the total share capital became 81.7176 million shares, and it was renamed "Guangxi Wuzhou Zhongheng Group Co., Ltd.", completing industrial and commercial registration changes in January 1997. In October 2000, it issued 45 million RMB ordinary shares via an online public offering on the Shanghai Stock Exchange. Upon successful issuance, the company became a listed company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangxi Investment Group Co., Ltd. General Legal Person 85934.36 26.99
2 Guangxi Guangtou Pharmaceutical Health Industry Group Co., Ltd. General Legal Person 10425.32 3.27
3 Central Huijin Asset Management Co., Ltd. Special Legal Person 4978.08 1.56
4 Southern China Securities 1000 ETF Fund 2423.75 0.76
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 2408.94 0.76
6 ChinaAMC China Securities Traditional Chinese Medicine ETF Fund 1655.74 0.52
7 ChinaAMC China Securities 1000 ETF Fund 1440.69 0.45
8 GF China Securities 1000 ETF Fund 1114.05 0.35
9 Xinhua Industry Leading Theme Stock Fund Fund 37.32 0.01

5. Concept Sectors

  • Venture Capital
  • Baijiu Concept
  • Mask Protection
  • Helicobacter Pylori
  • Hepatitis Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Financial Holdings
  • Low-Profit Stocks
  • National Team (China Securities Finance & Central Huijin)
  • Equity Transfer
  • Debt-to-Asset Management Companies (AMC)
  • Low-Price Stocks
  • Commitment Not to Reduce Holdings
  • CSI Buyback Index
  • SSE 580 Index

Remarks

  • Data update date: 2025-11-01
  • Data source: Public Market Information